Latest Altium Capital Management LP Stock Portfolio
Altium Capital Management LP Performance:
2024 Q3: 6.9%YTD: 24.34%2023: 0.56%
Performance for 2024 Q3 is 6.9%, and YTD is 24.34%, and 2023 is 0.56%.
About Altium Capital Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Altium Capital Management LP reported an equity portfolio of $339.7 Millions as of 30 Sep, 2024.
The top stock holdings of Altium Capital Management LP are VERA, ADMA, SRPT. The fund has invested 8.9% of it's portfolio in VERA THERAPEUTICS INC and 8% of portfolio in ADMA BIOLOGICS INC.
The fund managers got completely rid off ALIMERA SCIENCES INC (ALIM), ARGENX SE and CYBIN INC (CYBN) stocks. They significantly reduced their stock positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX), MILESTONE PHARMACEUTICALS IN (MIST) and INSMED INC (INSM). Altium Capital Management LP opened new stock positions in EDWARDS LIFESCIENCES CORP (EW), GLAUKOS CORP (GKOS) and MERIT MED SYS INC (MMSI). The fund showed a lot of confidence in some stocks as they added substantially to CINGULATE INC (CING), SAREPTA THERAPEUTICS INC (SRPT) and PERSPECTIVE THERAPEUTICS INC.
The top stock holdings of Altium Capital Management LP are VERA, ADMA, SRPT. The fund has invested 8.9% of it's portfolio in VERA THERAPEUTICS INC and 8% of portfolio in ADMA BIOLOGICS INC.
The fund managers got completely rid off ALIMERA SCIENCES INC (ALIM), ARGENX SE and CYBIN INC (CYBN) stocks. They significantly reduced their stock positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX), MILESTONE PHARMACEUTICALS IN (MIST) and INSMED INC (INSM). Altium Capital Management LP opened new stock positions in EDWARDS LIFESCIENCES CORP (EW), GLAUKOS CORP (GKOS) and MERIT MED SYS INC (MMSI). The fund showed a lot of confidence in some stocks as they added substantially to CINGULATE INC (CING), SAREPTA THERAPEUTICS INC (SRPT) and PERSPECTIVE THERAPEUTICS INC.
Altium Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Altium Capital Management LP made a return of 6.9% in the last quarter. In trailing 12 months, it's portfolio return was 40.67%.
New Buys
| Ticker | $ Bought |
|---|---|
| edwards lifesciences corp | 14,649,800 |
| glaukos corp | 10,031,600 |
| merit med sys inc | 8,400,550 |
| vaxcyte inc | 8,227,440 |
| arrowhead pharmaceuticals in | 6,876,350 |
| irhythm technologies inc | 6,384,640 |
| evolus inc | 5,751,000 |
| establishment labs hldgs inc | 5,668,370 |
New stocks bought by Altium Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| cingulate inc | 1,100 |
| sarepta therapeutics inc | 107 |
| perspective therapeutics inc | 51.48 |
| zevra therapeutics inc | 46.25 |
| axsome therapeutics inc | 16.00 |
| outlook therapeutics inc | 7.92 |
| viking therapeutics inc | 3.28 |
| the realreal inc | 1.58 |
Additions to existing portfolio by Altium Capital Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| moonlake immunotherapeutics | -65.22 |
| milestone pharmaceuticals in | -56.54 |
| insmed inc | -31.58 |
| catalyst pharmaceuticals inc | -23.00 |
| intra-cellular therapies inc | -20.21 |
| contineum therapeutics inc | -14.02 |
| oric pharmaceuticals inc | -12.35 |
| veru inc | -10.9 |
Altium Capital Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cybin inc | -3,781,400 |
| alimera sciences inc | -11,954,000 |
| allurion technologies inc | -967,512 |
| spruce biosciences inc | -419,941 |
| context therapeutics inc | -721,802 |
| achieve life sciences inc | -1,016,660 |
| biovie inc | -793,928 |
| aprea therapeutics inc | -558,392 |
Altium Capital Management LP got rid off the above stocks
Sector Distribution
Altium Capital Management LP has about 85% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85 |
| Others | 13.6 |
| Consumer Cyclical | 1.3 |
Market Cap. Distribution
Altium Capital Management LP has about 13.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 42 |
| SMALL-CAP | 21.1 |
| UNALLOCATED | 13.6 |
| LARGE-CAP | 13.5 |
| MICRO-CAP | 9 |
Stocks belong to which Index?
About 59.2% of the stocks held by Altium Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54.8 |
| Others | 40.8 |
| S&P 500 | 4.4 |
Altium Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Altium Capital Management LP
Altium Capital Management LP has 75 stocks in it's portfolio. About 47.3% of the portfolio is in top 10 stocks. CRBP proved to be the most loss making stock for the portfolio. ADMA was the most profitable stock for Altium Capital Management LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACHV | achieve life sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADMA | adma biologics inc | 8.00 | 1,360,000 | 27,186,400 | reduced | -9.93 | ||
| ALIM | alimera sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APDN | applied dna sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APRE | aprea therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARWR | arrowhead pharmaceuticals in | 2.02 | 355,000 | 6,876,350 | new | |||
| ATRC | atricure inc | 0.45 | 54,000 | 1,514,160 | new | |||
| AXSM | axsome therapeutics inc | 1.53 | 58,000 | 5,212,460 | added | 16.00 | ||
| BCYC | bicycle therapeutics plc | 0.57 | 85,000 | 1,923,550 | new | |||
| BIVI | biovie inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BTTR | better choice co inc | 0.08 | 133,117 | 278,215 | new | |||
| CAPR | capricor therapeutics inc | 1.28 | 285,000 | 4,334,850 | new | |||
| CEAD | cea industries inc | 0.00 | 250,000 | 6,275 | unchanged | 0.00 | ||
| CETX | cemtrex inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CING | cingulate inc | 0.01 | 270,000 | 18,684 | added | 1,100 | ||
| CLRB | cellectar biosciences inc | 0.14 | 215,000 | 460,100 | new | |||
| CNTX | context therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CPRX | catalyst pharmaceuticals inc | 2.25 | 385,000 | 7,653,800 | reduced | -23.00 | ||
| CRBP | corbus pharmaceuticals hldgs | 1.18 | 195,000 | 4,022,850 | new | |||
| CTMX | cytomx therapeutics inc | 0.32 | 915,000 | 1,079,700 | new | |||